A detailed history of Us Bancorp \De\ transactions in Celcuity Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 548 shares of CELC stock, worth $6,795. This represents 0.0% of its overall portfolio holdings.

Number of Shares
548
Previous 548 -0.0%
Holding current value
$6,795
Previous $8,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$5.79 - $11.78 $201,891 - $410,756
-34,869 Reduced 98.45%
548 $4,000
Q4 2019

Feb 04, 2020

SELL
$9.47 - $16.71 $75,760 - $133,680
-8,000 Reduced 18.43%
35,417 $377,000
Q3 2018

Nov 01, 2018

BUY
$20.96 - $30.77 $910,020 - $1.34 Million
43,417 New
43,417 $1.25 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $185M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.